CVS introduces cheaper EpiPen competitor

WOONSOCKET, R.I. — CVS introduced a generic version of injectable epinephrine to compete with Mylan’s EpiPen at all of its locations. The product carries a cash price of $109.99 for a two-pack.

“We recognized the urgent need for a less-expensive epinephrine auto-injector, and are proud to offer a low-cost option at all CVS Pharmacy locations,” CVS stated in a news release. “Patients can now purchase the authorized generic for Adrenaclick at a cash price of $109.99 for a two-pack — the lowest cash price in the market. This authorized generic is a Food and Drug Administration (FDA)-approved device with the same active ingredient as other epinephrine auto-injector devices.”

Before patients switch from EpiPen, they should speak with their prescriber about whether the authorized generic for Adrenaclick is a good fit for their specific medical needs, CVS noted. “The prescriber can then write a prescription for an ‘epinephrine auto-injector’ to ensure the lowest-cost product is filled. Patients who already have a prescription on file with CVS Pharmacy can ask their pharmacist to check with the prescriber about making the change.”

“We’re encouraged to see national efforts to make epinephrine auto-injectors more affordable and more available to Americans across the country,” said Cary Sensett, M.D., Ph.D., president and CEO of the Asthma and Allergy Foundation of America. “Partnerships that increase access to vital medications are key in helping those suffering from life-threatening allergies.”